Literature DB >> 25859398

Integral dose: Comparison between four techniques for prostate radiotherapy.

Krzysztof Ślosarek1, Wojciech Osewski2, Aleksandra Grządziel1, Michał Radwan1, Łukasz Dolla1, Marta Szlag1, Małgorzata Stąpór-Fudzińska1.   

Abstract

AIM: Comparisons of integral dose delivered to the treatment planning volume and to the whole patient body during stereotactic, helical and intensity modulated radiotherapy of prostate.
BACKGROUND: Multifield techniques produce large volumes of low dose inside the patient body. Delivered dose could be the result of the cytotoxic injuries of the cells even away from the treatment field. We calculated the total dose absorbed in the patient body for four radiotherapy techniques to investigate whether some methods have a potential to reduce the exposure to the patient.
MATERIALS AND METHODS: We analyzed CyberKnife plans for 10 patients with localized prostate cancer. Five alternative plans for each patient were calculated with the VMAT, IMRT and TomoTherapy techniques. Alternative dose distributions were calculated to achieve the same coverage for PTV. Integral Dose formula was used to calculate the total dose delivered to the PTV and whole patient body.
RESULTS: Analysis showed that the same amount of dose was deposited to the treated volume despite different methods of treatment delivery. The mean values of total dose delivered to the whole patient body differed significantly for each treatment technique. The highest integral dose in the patient's body was at the TomoTherapy and CyberKnife treatment session. VMAT was characterized by the lowest integral dose deposited in the patient body.
CONCLUSIONS: The highest total dose absorbed in normal tissue was observed with the use of a robotic radiosurgery system and TomoTherapy. These results demonstrate that the exposure of healthy tissue is a dosimetric factor which differentiates the dose delivery methods.

Entities:  

Keywords:  CyberKnife; Integral dose; Prostate cancer; TomoTherapy; VMAT

Year:  2014        PMID: 25859398      PMCID: PMC4338216          DOI: 10.1016/j.rpor.2014.10.010

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  18 in total

1.  Dosimetric verification of the anisotropic analytical algorithm for radiotherapy treatment planning.

Authors:  Christopher M Bragg; John Conway
Journal:  Radiother Oncol       Date:  2006-11-27       Impact factor: 6.280

2.  Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain?

Authors:  Ulrich Hermanto; Erik K Frija; Mingfwu J Lii; Eric L Chang; Anita Mahajan; Shiao Y Woo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-08       Impact factor: 7.038

3.  Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer.

Authors:  Carlos Vargas; Amber Fryer; Chaitali Mahajan; Daniel Indelicato; David Horne; Angela Chellini; Craig McKenzie; Paula Lawlor; Randal Henderson; Zuofeng Li; Liyong Lin; Kenneth Olivier; Sameer Keole
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-27       Impact factor: 7.038

4.  CyberKnife in the treatment of prostate cancer: a revolutionary system.

Authors:  Giuseppe Morgia; Costantino De Renzis
Journal:  Eur Urol       Date:  2009-02-23       Impact factor: 20.096

5.  Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.

Authors:  Johanne Hermesse; Sylvie Biver; Nicolas Jansen; Eric Lenaerts; Philippe Nickers
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

6.  RapidArc radiotherapy planning for prostate cancer: single-arc and double-arc techniques vs. intensity-modulated radiotherapy.

Authors:  Henry C K Sze; Michael C H Lee; Wai-Man Hung; Tsz-Kok Yau; Anne W M Lee
Journal:  Med Dosim       Date:  2011-09-16       Impact factor: 1.482

Review 7.  Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy.

Authors:  V S Khoo
Journal:  Clin Oncol (R Coll Radiol)       Date:  2005-10       Impact factor: 4.126

8.  A comparison between anisotropic analytical and multigrid superposition dose calculation algorithms in radiotherapy treatment planning.

Authors:  Vincent W C Wu; Teddy K H Tse; Cola L M Ho; Eric C Y Yeung
Journal:  Med Dosim       Date:  2013-03-25       Impact factor: 1.482

9.  Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer.

Authors:  Daniel R Zwahlen; Jeremy D Ruben; Phillip Jones; Frank Gagliardi; Jeremy L Millar; Uwe Schneider
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-01       Impact factor: 7.038

10.  Treatment plan comparison between stereotactic body radiation therapy techniques for prostate cancer: non-isocentric CyberKnife versus isocentric RapidArc.

Authors:  Yu-Wei Lin; Kuei-Hua Lin; Hsiu-Wen Ho; Hsiu-Man Lin; Li-Ching Lin; Steve P Lee; Chen-Shou Chui
Journal:  Phys Med       Date:  2014-04-13       Impact factor: 2.685

View more
  14 in total

1.  Definitive-intent intensity-modulated radiation therapy provides similar outcomes to those previously published for definitive-intent three-dimensional conformal radiation therapy in dogs with primary brain tumors: A multi-institutional retrospective study.

Authors:  Nathaniel Van Asselt; Neil Christensen; Valeria Meier; Carla Rohrer Bley; Sarah Laliberte; Valerie J Poirier; Noopur Desai; Yi Chen; Michelle Turek
Journal:  Vet Radiol Ultrasound       Date:  2020-05-01       Impact factor: 1.363

2.  Dosimetric influence of filtered and flattening filter free photon beam on rapid arc (RA) radiotherapy planning in case of cervix carcinoma.

Authors:  Lalit Kumar; Girigesh Yadav; Kothanda Raman Samuvel; Manindra Bhushan; Pawan Kumar; Mahammood Suhail; Manoj Pal
Journal:  Rep Pract Oncol Radiother       Date:  2016-10-17

3.  Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: Analysis of quality of life and toxicity, PCG GU 002.

Authors:  Carlos Enrique Vargas; William Fred Hartsell; Megan Dunn; Sameer Ramchandra Keole; Lucius Doh; John Chang; Gary Lynn Larson
Journal:  Rep Pract Oncol Radiother       Date:  2016-03-04

4.  Influence of optimizing protocol choice on the integral dose value in prostate radiotherapy planning by dynamic techniques - Pilot study.

Authors:  Anna Zaleska; Krzysztof Bogaczyk; Tomasz Piotrowski
Journal:  Rep Pract Oncol Radiother       Date:  2017-08-17

5.  Dosimetric impact in the dose-volume histograms of rectal and vesical wall contouring in prostate cancer IMRT treatments.

Authors:  Laura Gómez; Carlos Andrés; Antonio Ruiz
Journal:  Rep Pract Oncol Radiother       Date:  2017-04-21

6.  Comparison of treatment planning parameters for dose painting head and neck plans delivered with tomotherapy.

Authors:  Malgorzata Skórska; Tomasz Piotrowski; Adam Ryczkowski; Joanna Kaźmierska
Journal:  Br J Radiol       Date:  2016-02-01       Impact factor: 3.039

7.  Cost Analysis of Selected Radiotherapeutic Modalities for Prostate Cancer Treatment-Czech Republic Case Study for the Purposes of Hospital Based HTA.

Authors:  Petra Hospodková; Tomáš Husár; Barbora Klíčová; Lucie Severová; Karel Šrédl; Roman Svoboda
Journal:  Healthcare (Basel)       Date:  2021-01-19

8.  Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.

Authors:  Vanessa Da Silva Mendes; Lukas Nierer; Minglun Li; Stefanie Corradini; Michael Reiner; Florian Kamp; Maximilian Niyazi; Christopher Kurz; Guillaume Landry; Claus Belka
Journal:  Radiat Oncol       Date:  2021-07-21       Impact factor: 3.481

9.  Cyberknife, Helical Tomotherapy and Rapid Arc SIB-SBRT Treatment Plan Comparison for Carcinoma Prostate.

Authors:  Bijina T K; Ganesh K M; Pichandi A; Muthuselvi C A
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01

10.  Dosimetric comparison among cyberknife, helical tomotherapy and VMAT for hypofractionated treatment in localized prostate cancer.

Authors:  Marcello Serra; Gianluca Ametrano; Valentina Borzillo; Maria Quarto; Matteo Muto; Rossella Di Franco; Savino Federica; Filomena Loffredo; Muto Paolo
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.